Syncromune, Inc.

Amendment
CIK: 0001955312·Biotechnology·DELAWARE·Filed: May 11, 2026
Total Offering

$144,828,791

Amount Sold

$144,828,791

Investors

77

First Sale

Dec 3, 2024

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Charles J. Link
Eamonn Hobbs
Joseph Gerardi
Agustin Gago
Joseph C. Maroon
Douglas G. Watson
Jeffrey L. Cleland
Norman Schwartz
Kerri-Ann Millar
Stephen Dale

Company

Syncromune, Inc.

2919 E. COMMERCIAL BLVD., SUITE 200

FORT LAUDERDALE, FL, 33308

518-796-6110

SEC Filing

0001231919-26-000472

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free